APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Glargine

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Selected research

Market Analysis & Forecast

Global Insulin Glargine Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchInsulin Glargine Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Glargine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Insulin Glargine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Glargine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Glargine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile (according to the insulin glargine package insert).

Global Insulin Glargine key players include Sanofi-Aventis, Ganlee, etc. Global top two manufacturers hold a share nearly 50%.

USA is the largest market, with a share over 60%, followed by China, and Europe, both have a share about 35 percent.

Read the full market overview

In terms of product, Pre-filled Syringe is the largest segment, with a share about 75%. And in terms of application, the largest application is Treat type2 diabetes, followed by Treat type1 diabetes.

This report presents an overview of global market for Insulin Glargine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Insulin Glargine, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin Glargine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin Glargine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Insulin Glargine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Insulin Glargine sales, projected growth trends, production technology, application and end-user industry.

Insulin Glargine Segment by Company

Sanofi-Aventis

Ganlee

Biocon

Insulin Glargine Segment by Type

Single Dose Vial

Pre-filled Syringe

Insulin Glargine Segment by Application

Treat Type2 Diabetes

Treat Type1 Diabetes

Insulin Glargine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glargine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Glargine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glargine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Insulin Glargine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Insulin Glargine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Insulin Glargine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Dose Vial Major Manufacturers Table 3. Pre-filled Syringe Major Manufacturers Table 4. Global Insulin Glargine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Treat Type2 Diabetes Major Manufacturers Table 6. Treat Type1 Diabetes Major Manufacturers Table 7. Insulin Glargine Industry Trends Table 8. Insulin Glargine Industry Drivers Table 9. Insulin Glargine Industry Opportunities and Challenges Table 10. Insulin Glargine Industry Restraints Table 11. Global Insulin Glargine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Insulin Glargine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Insulin Glargine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Insulin Glargine Revenue Market Share by Region (2021-2026) Table 15. Global Insulin Glargine Revenue Market Share by Region (2027-2032) Table 16. Global Insulin Glargine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M mL) Table 17. Global Insulin Glargine Sales by Region (2021-2026) & (M mL) Table 18. Global Insulin Glargine Sales by Region (2027-2032) & (M mL) Table 19. Global Insulin Glargine Sales Market Share by Region (2021-2026) Table 20. Global Insulin Glargine Sales Market Share by Region (2027-2032) Table 21. Global Insulin Glargine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Insulin Glargine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Insulin Glargine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Insulin Glargine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Insulin Glargine Sales Price (USD/mL) of Manufacturers (2021-2026) Table 26. Global Insulin Glargine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Insulin Glargine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Insulin Glargine Manufacturers, Product Type & Application Table 29. Global Insulin Glargine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Insulin Glargine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Insulin Glargine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Insulin Glargine Revenue Market Share by Type (2021-2026) Table 36. Global Insulin Glargine Revenue Market Share by Type (2027-2032) Table 37. Global Insulin Glargine Sales by Type 2021 VS 2025 VS 2032 (M mL) Table 38. Global Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 39. Global Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 40. Global Insulin Glargine Sales Market Share by Type (2021-2026) Table 41. Global Insulin Glargine Sales Market Share by Type (2027-2032) Table 42. Global Insulin Glargine Price by Type (2021-2026) & (USD/mL) Table 43. Global Insulin Glargine Price by Type (2027-2032) & (USD/mL) Table 44. Global Insulin Glargine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Insulin Glargine Revenue Market Share by Application (2021-2026) Table 48. Global Insulin Glargine Revenue Market Share by Application (2027-2032) Table 49. Global Insulin Glargine Sales by Application 2021 VS 2025 VS 2032 (M mL) Table 50. Global Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 51. Global Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 52. Global Insulin Glargine Sales Market Share by Application (2021-2026) Table 53. Global Insulin Glargine Sales Market Share by Application (2027-2032) Table 54. Global Insulin Glargine Price by Application (2021-2026) & (USD/mL) Table 55. Global Insulin Glargine Price by Application (2027-2032) & (USD/mL) Table 56. Sanofi-Aventis Company Information Table 57. Sanofi-Aventis Business Overview Table 58. Sanofi-Aventis Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 59. Sanofi-Aventis Insulin Glargine Product Portfolio Table 60. Sanofi-Aventis Recent Development Table 61. Ganlee Company Information Table 62. Ganlee Business Overview Table 63. Ganlee Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 64. Ganlee Insulin Glargine Product Portfolio Table 65. Ganlee Recent Development Table 66. Biocon Company Information Table 67. Biocon Business Overview Table 68. Biocon Insulin Glargine Sales (M mL), Revenue (US$ Million), Price (USD/mL) and Gross Margin (2021-2026) Table 69. Biocon Insulin Glargine Product Portfolio Table 70. Biocon Recent Development Table 71. North America Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 72. North America Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 73. North America Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 74. North America Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 75. North America Insulin Glargine Sales Price by Type (2021-2026) & (USD/mL) Table 76. North America Insulin Glargine Sales Price by Type (2027-2032) & (USD/mL) Table 77. North America Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 80. North America Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 81. North America Insulin Glargine Sales Price by Application (2021-2026) & (USD/mL) Table 82. North America Insulin Glargine Sales Price by Application (2027-2032) & (USD/mL) Table 83. North America Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. North America Insulin Glargine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 85. North America Insulin Glargine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 86. North America Insulin Glargine Sales by Country (2021 VS 2025 VS 2032) & (M mL) Table 87. North America Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 88. North America Insulin Glargine Sales by Country (2027-2032) & (M mL) Table 89. North America Insulin Glargine Sales Price by Country (2021-2026) & (USD/mL) Table 90. North America Insulin Glargine Sales Price by Country (2027-2032) & (USD/mL) Table 91. United States Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 92. Canada Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 93. Mexico Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 94. Europe Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 97. Europe Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 98. Europe Insulin Glargine Sales Price by Type (2021-2026) & (USD/mL) Table 99. Europe Insulin Glargine Sales Price by Type (2027-2032) & (USD/mL) Table 100. Europe Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 103. Europe Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 104. Europe Insulin Glargine Sales Price by Application (2021-2026) & (USD/mL) Table 105. Europe Insulin Glargine Sales Price by Application (2027-2032) & (USD/mL) Table 106. Europe Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Europe Insulin Glargine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. Europe Insulin Glargine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. Europe Insulin Glargine Sales by Country (2021 VS 2025 VS 2032) & (M mL) Table 110. Europe Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 111. Europe Insulin Glargine Sales by Country (2027-2032) & (M mL) Table 112. Europe Insulin Glargine Sales Price by Country (2021-2026) & (USD/mL) Table 113. Europe Insulin Glargine Sales Price by Country (2027-2032) & (USD/mL) Table 114. Germany Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 115. France Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 116. U.K. Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 117. Italy Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 118. Russia Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 119. Spain Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 120. Netherlands Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 121. Switzerland Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 122. Sweden Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 123. Poland Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 124. China Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 125. China Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 126. China Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 127. China Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 128. China Insulin Glargine Sales Price by Type (2021-2026) & (USD/mL) Table 129. China Insulin Glargine Sales Price by Type (2027-2032) & (USD/mL) Table 130. China Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 131. China Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 132. China Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 133. China Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 134. China Insulin Glargine Sales Price by Application (2021-2026) & (USD/mL) Table 135. China Insulin Glargine Sales Price by Application (2027-2032) & (USD/mL) Table 136. Asia Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 137. Asia Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 138. Asia Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 139. Asia Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 140. Asia Insulin Glargine Sales Price by Type (2021-2026) & (USD/mL) Table 141. Asia Insulin Glargine Sales Price by Type (2027-2032) & (USD/mL) Table 142. Asia Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 143. Asia Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 144. Asia Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 145. Asia Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 146. Asia Insulin Glargine Sales Price by Application (2021-2026) & (USD/mL) Table 147. Asia Insulin Glargine Sales Price by Application (2027-2032) & (USD/mL) Table 148. Asia Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Asia Insulin Glargine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Asia Insulin Glargine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Asia Insulin Glargine Sales by Country (2021 VS 2025 VS 2032) & (M mL) Table 152. Asia Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 153. Asia Insulin Glargine Sales by Country (2027-2032) & (M mL) Table 154. Asia Insulin Glargine Sales Price by Country (2021-2026) & (USD/mL) Table 155. Asia Insulin Glargine Sales Price by Country (2027-2032) & (USD/mL) Table 156. Japan Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 157. South Korea Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 158. India Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 159. Australia Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 160. Taiwan Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 161. Southeast Asia Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 162. SAMEA Insulin Glargine Revenue by Type (2021-2026) & (US$ Million) Table 163. SAMEA Insulin Glargine Revenue by Type (2027-2032) & (US$ Million) Table 164. SAMEA Insulin Glargine Sales by Type (2021-2026) & (M mL) Table 165. SAMEA Insulin Glargine Sales by Type (2027-2032) & (M mL) Table 166. SAMEA Insulin Glargine Sales Price by Type (2021-2026) & (USD/mL) Table 167. SAMEA Insulin Glargine Sales Price by Type (2027-2032) & (USD/mL) Table 168. SAMEA Insulin Glargine Revenue by Application (2021-2026) & (US$ Million) Table 169. SAMEA Insulin Glargine Revenue by Application (2027-2032) & (US$ Million) Table 170. SAMEA Insulin Glargine Sales by Application (2021-2026) & (M mL) Table 171. SAMEA Insulin Glargine Sales by Application (2027-2032) & (M mL) Table 172. SAMEA Insulin Glargine Sales Price by Application (2021-2026) & (USD/mL) Table 173. SAMEA Insulin Glargine Sales Price by Application (2027-2032) & (USD/mL) Table 174. SAMEA Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. SAMEA Insulin Glargine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. SAMEA Insulin Glargine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. SAMEA Insulin Glargine Sales by Country (2021 VS 2025 VS 2032) & (M mL) Table 178. SAMEA Insulin Glargine Sales by Country (2021-2026) & (M mL) Table 179. SAMEA Insulin Glargine Sales by Country (2027-2032) & (M mL) Table 180. SAMEA Insulin Glargine Sales Price by Country (2021-2026) & (USD/mL) Table 181. SAMEA Insulin Glargine Sales Price by Country (2027-2032) & (USD/mL) Table 182. Brazil Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 183. Argentina Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 184. Chile Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 185. Colombia Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 186. Peru Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 187. Saudi Arabia Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 188. Israel Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 189. UAE Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 190. Turkey Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 191. Iran Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 192. Egypt Insulin Glargine Revenue (2021-2032) & (US$ Million) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Insulin Glargine Distributors List Table 196. Insulin Glargine Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Insulin Glargine Image Figure 2. Global Insulin Glargine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Glargine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Dose Vial Image Figure 5. Pre-filled Syringe Image Figure 6. Global Insulin Glargine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Insulin Glargine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Treat Type2 Diabetes Image Figure 9. Treat Type1 Diabetes Image Figure 10. Global Insulin Glargine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Insulin Glargine Revenue (2021-2032) & (US$ Million) Figure 12. Global Insulin Glargine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Insulin Glargine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Insulin Glargine Revenue Market Share by Region (2021-2032) Figure 15. Global Insulin Glargine Sales (2021-2032) & (M mL) Figure 16. Global Insulin Glargine Sales by Region: 2021 VS 2025 VS 2032 (M mL) Figure 17. Global Insulin Glargine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Insulin Glargine Sales YoY (2021-2032) & (M mL) Figure 19. Europe Insulin Glargine Sales YoY (2021-2032) & (M mL) Figure 20. China Insulin Glargine Sales YoY (2021-2032) & (M mL) Figure 21. Asia (Excluding China) Insulin Glargine Sales YoY (2021-2032) & (M mL) Figure 22. South America, Middle East and Africa Insulin Glargine Sales YoY (2021-2032) & (M mL) Figure 23. Global Insulin Glargine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Insulin Glargine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Insulin Glargine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Insulin Glargine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Insulin Glargine Revenue Market Share by Type (2021-2032) Figure 29. Global Insulin Glargine Sales by Type (2021 VS 2025 VS 2032) & (M mL) Figure 30. Global Insulin Glargine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Insulin Glargine Sales Market Share by Type (2021-2032) Figure 32. Global Insulin Glargine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Insulin Glargine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Insulin Glargine Revenue Market Share by Application (2021-2032) Figure 35. Global Insulin Glargine Sales by Application (2021 VS 2025 VS 2032) & (M mL) Figure 36. Global Insulin Glargine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Insulin Glargine Sales Market Share by Application (2021-2032) Figure 38. North America Insulin Glargine Revenue Share by Type (2021-2032) Figure 39. North America Insulin Glargine Sales Share by Type (2021-2032) Figure 40. North America Insulin Glargine Revenue Share by Application (2021-2032) Figure 41. North America Insulin Glargine Sales Share by Application (2021-2032) Figure 42. North America Insulin Glargine Revenue Share by Country (2021-2032) Figure 43. North America Insulin Glargine Sales Share by Country (2021-2032) Figure 44. Europe Insulin Glargine Revenue Share by Type (2021-2032) Figure 45. Europe Insulin Glargine Sales Share by Type (2021-2032) Figure 46. Europe Insulin Glargine Revenue Share by Application (2021-2032) Figure 47. Europe Insulin Glargine Sales Share by Application (2021-2032) Figure 48. Europe Insulin Glargine Revenue Share by Country (2021-2032) Figure 49. Europe Insulin Glargine Sales Share by Country (2021-2032) Figure 50. China Insulin Glargine Revenue Share by Type (2021-2032) Figure 51. China Insulin Glargine Sales Share by Type (2021-2032) Figure 52. China Insulin Glargine Revenue Share by Application (2021-2032) Figure 53. China Insulin Glargine Sales Share by Application (2021-2032) Figure 54. Asia Insulin Glargine Revenue Share by Type (2021-2032) Figure 55. Asia Insulin Glargine Sales Share by Type (2021-2032) Figure 56. Asia Insulin Glargine Revenue Share by Application (2021-2032) Figure 57. Asia Insulin Glargine Sales Share by Application (2021-2032) Figure 58. Asia Insulin Glargine Revenue Share by Country (2021-2032) Figure 59. Asia Insulin Glargine Sales Share by Country (2021-2032) Figure 60. SAMEA Insulin Glargine Revenue Share by Type (2021-2032) Figure 61. SAMEA Insulin Glargine Sales Share by Type (2021-2032) Figure 62. SAMEA Insulin Glargine Revenue Share by Application (2021-2032) Figure 63. SAMEA Insulin Glargine Sales Share by Application (2021-2032) Figure 64. SAMEA Insulin Glargine Revenue Share by Country (2021-2032) Figure 65. SAMEA Insulin Glargine Sales Share by Country (2021-2032) Figure 66. Insulin Glargine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Insulin Glargine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • Treat Type2 Diabetes
  • Treat Type1 Diabetes
Companies covered
  • Sanofi-Aventis
  • Ganlee
  • Biocon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Insulin Glargine Market by Type
  3. 1.2.1 Global Insulin Glargine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Dose Vial
  5. 1.2.3 Pre-filled Syringe
  6. 1.3 Insulin Glargine Market by Application
  7. 1.3.1 Global Insulin Glargine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Treat Type2 Diabetes
  9. 1.3.3 Treat Type1 Diabetes
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Insulin Glargine Market Dynamics
  1. 2.1 Insulin Glargine Industry Trends
  2. 2.2 Insulin Glargine Industry Drivers
  3. 2.3 Insulin Glargine Industry Opportunities and Challenges
  4. 2.4 Insulin Glargine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Insulin Glargine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Insulin Glargine Revenue by Region
  3. 3.2.1 Global Insulin Glargine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Insulin Glargine Revenue by Region (2021-2026)
  5. 3.2.3 Global Insulin Glargine Revenue by Region (2027-2032)
  6. 3.2.4 Global Insulin Glargine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Insulin Glargine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Insulin Glargine Sales by Region
  9. 3.4.1 Global Insulin Glargine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Insulin Glargine Sales by Region (2021-2026)
  11. 3.4.3 Global Insulin Glargine Sales by Region (2027-2032)
  12. 3.4.4 Global Insulin Glargine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Insulin Glargine Revenue by Manufacturers
  2. 4.1.1 Global Insulin Glargine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Insulin Glargine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Insulin Glargine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Insulin Glargine Sales by Manufacturers
  6. 4.2.1 Global Insulin Glargine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Insulin Glargine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Insulin Glargine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Insulin Glargine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Insulin Glargine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Insulin Glargine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Insulin Glargine Manufacturers, Product Type & Application
  13. 4.7 Global Insulin Glargine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Insulin Glargine Market CR5 and HHI
  16. 4.8.2 2025 Insulin Glargine Tier 1, Tier 2, and Tier 3
5 Insulin Glargine Market by Type
  1. 5.1 Global Insulin Glargine Revenue by Type
  2. 5.1.1 Global Insulin Glargine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Insulin Glargine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Insulin Glargine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Insulin Glargine Sales by Type
  6. 5.2.1 Global Insulin Glargine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Glargine Sales by Type (2021-2032) & (M mL)
  8. 5.2.3 Global Insulin Glargine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Insulin Glargine Price by Type
6 Insulin Glargine Market by Application
  1. 6.1 Global Insulin Glargine Revenue by Application
  2. 6.1.1 Global Insulin Glargine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Insulin Glargine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Insulin Glargine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Insulin Glargine Sales by Application
  6. 6.2.1 Global Insulin Glargine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Insulin Glargine Sales by Application (2021-2032) & (M mL)
  8. 6.2.3 Global Insulin Glargine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Insulin Glargine Price by Application
7 Company Profiles
  1. 7.1 Sanofi-Aventis
  2. 7.1.1 Sanofi-Aventis Company Information
  3. 7.1.2 Sanofi-Aventis Business Overview
  4. 7.1.3 Sanofi-Aventis Insulin Glargine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi-Aventis Insulin Glargine Product Portfolio
  6. 7.1.5 Sanofi-Aventis Recent Developments
  7. 7.2 Ganlee
  8. 7.2.1 Ganlee Company Information
  9. 7.2.2 Ganlee Business Overview
  10. 7.2.3 Ganlee Insulin Glargine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Ganlee Insulin Glargine Product Portfolio
  12. 7.2.5 Ganlee Recent Developments
  13. 7.3 Biocon
  14. 7.3.1 Biocon Company Information
  15. 7.3.2 Biocon Business Overview
  16. 7.3.3 Biocon Insulin Glargine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Biocon Insulin Glargine Product Portfolio
  18. 7.3.5 Biocon Recent Developments
8 North America
  1. 8.1 North America Insulin Glargine Market Size by Type
  2. 8.1.1 North America Insulin Glargine Revenue by Type (2021-2032)
  3. 8.1.2 North America Insulin Glargine Sales by Type (2021-2032)
  4. 8.1.3 North America Insulin Glargine Price by Type (2021-2032)
  5. 8.2 North America Insulin Glargine Market Size by Application
  6. 8.2.1 North America Insulin Glargine Revenue by Application (2021-2032)
  7. 8.2.2 North America Insulin Glargine Sales by Application (2021-2032)
  8. 8.2.3 North America Insulin Glargine Price by Application (2021-2032)
  9. 8.3 North America Insulin Glargine Market Size by Country
  10. 8.3.1 North America Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Insulin Glargine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Insulin Glargine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Insulin Glargine Market Size by Type
  2. 9.1.1 Europe Insulin Glargine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Insulin Glargine Sales by Type (2021-2032)
  4. 9.1.3 Europe Insulin Glargine Price by Type (2021-2032)
  5. 9.2 Europe Insulin Glargine Market Size by Application
  6. 9.2.1 Europe Insulin Glargine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Insulin Glargine Sales by Application (2021-2032)
  8. 9.2.3 Europe Insulin Glargine Price by Application (2021-2032)
  9. 9.3 Europe Insulin Glargine Market Size by Country
  10. 9.3.1 Europe Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Insulin Glargine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Insulin Glargine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Insulin Glargine Market Size by Type
  2. 10.1.1 China Insulin Glargine Revenue by Type (2021-2032)
  3. 10.1.2 China Insulin Glargine Sales by Type (2021-2032)
  4. 10.1.3 China Insulin Glargine Price by Type (2021-2032)
  5. 10.2 China Insulin Glargine Market Size by Application
  6. 10.2.1 China Insulin Glargine Revenue by Application (2021-2032)
  7. 10.2.2 China Insulin Glargine Sales by Application (2021-2032)
  8. 10.2.3 China Insulin Glargine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Insulin Glargine Market Size by Type
  2. 11.1.1 Asia Insulin Glargine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Insulin Glargine Sales by Type (2021-2032)
  4. 11.1.3 Asia Insulin Glargine Price by Type (2021-2032)
  5. 11.2 Asia Insulin Glargine Market Size by Application
  6. 11.2.1 Asia Insulin Glargine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Insulin Glargine Sales by Application (2021-2032)
  8. 11.2.3 Asia Insulin Glargine Price by Application (2021-2032)
  9. 11.3 Asia Insulin Glargine Market Size by Country
  10. 11.3.1 Asia Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Insulin Glargine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Insulin Glargine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Insulin Glargine Market Size by Type
  2. 12.1.1 SAMEA Insulin Glargine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Insulin Glargine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Insulin Glargine Price by Type (2021-2032)
  5. 12.2 SAMEA Insulin Glargine Market Size by Application
  6. 12.2.1 SAMEA Insulin Glargine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Insulin Glargine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Insulin Glargine Price by Application (2021-2032)
  9. 12.3 SAMEA Insulin Glargine Market Size by Country
  10. 12.3.1 SAMEA Insulin Glargine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Insulin Glargine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Insulin Glargine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Insulin Glargine Value Chain Analysis
  2. 13.1.1 Insulin Glargine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Insulin Glargine Production Mode & Process
  6. 13.2 Insulin Glargine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Insulin Glargine Distributors
  9. 13.2.3 Insulin Glargine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst